SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000911916-17-000076
Filing Date
2017-03-01
Accepted
2017-03-01 12:20:12
Documents
1
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 16912
  Complete submission text file 0000911916-17-000076.txt   18865
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Issuer) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Marengere Luc (Reporting) CIK: 0001639971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37358 | Film No.: 17652652

Mailing Address 204, RUE NOTRE-DAME OUEST, BUREAU 350 MONTREAL A8 H2Y 1T3
Business Address 204, RUE NOTRE-DAME OUEST, BUREAU 350 MONTREAL A8 H2Y 1T3 514-931-4111
TVM Life Science Ventures VII L.P. (Reporting) CIK: 0001640880 (see all company filings)

State of Incorp.: XX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37358 | Film No.: 17652651